LIMA Peru’s Congress approved on Wednesday a law that will allow policymakers to cap interest rates on loans granted by banks, a controversial measure that…
Peruvian president Francisco Sagasti said on Wednesday his interim administration had negotiated vaccine supply deals with Sinopharm Group and AstraZeneca Plc, boosting prospects for a vaccination program that has been slow to take root in the hard-hit Andean nation.
2 Min Read
LIMA, Jan 8 (Reuters) - Peru has confirmed the first case of a highly transmissable variant of the coronavirus first found in Britain, the Ministry of Health said on Friday, as cases tick upwards and hospitals in some parts of the country warn of saturation.
The ministry said the person affected by the variant of the virus was a Peruvian citizen who lived and worked in the capital Lima and had not travelled abroad.
The authorities said the woman had attended family gatherings before Christmas and they would be tracing those she had contact with.
Peru has confirmed 1,026,090 coronavirus cases, with more than 38,000 deaths, according to data from the Ministry of Health published on Thursday. Peru is reporting 1,650 new infections on average each day, 19% of the cases reported during its mid-August peak, according to Reuters data.
By Reuters Staff
2 Min Read
FILE PHOTO: A signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang
LIMA (Reuters) -Peruvian president Francisco Sagasti said on Wednesday his interim administration had negotiated vaccine supply deals with Sinopharm Group and AstraZeneca Plc, boosting prospects for a vaccination program that has been slow to take root in the hard-hit Andean nation.
Sagasti said in a televised speech that his government had secured one million vaccine doses from Sinopharm for delivery in January. He said the deal was part of a larger agreement to purchase 38 million doses from the Chinese company.